174 related articles for article (PubMed ID: 36581425)
1. Prevalence of human papillomavirus in Wenzhou, China: a cross-sectional study of 127 938 outpatient women.
Zhang M; Chen G; Dai X; Wu Z; Huang H; Zheng Y
BMJ Open; 2022 Dec; 12(12):e066698. PubMed ID: 36581425
[TBL] [Abstract][Full Text] [Related]
2. Human Papilloma Virus Infection and Gene Subtypes Analysis in Women Undergoing Physical Examinations: A 2015-2020 Study in Wenzhou, China.
Gao Y; Zhang M; Zheng Y; Huang H; Xie H
Cancer Control; 2024; 31():10732748241257902. PubMed ID: 38783796
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.
Yao X; Li Q; Chen Y; Du Z; Huang Y; Zhou Y; Zhang J; Wang W; Zhang L; Xie J; Xu C; Ge Y; Zhou Y
Front Public Health; 2024; 12():1332696. PubMed ID: 38590815
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women.
Zhang H; Zhang S
Arch Gynecol Obstet; 2023 Jul; 308(1):35-41. PubMed ID: 35904609
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China.
Wang T; Luan L; Deng J; Liu N; Wu Q; Gong T; Zhu J; Zhang Z; Zhang J
Hum Vaccin Immunother; 2023 Aug; 19(2):2241309. PubMed ID: 37519009
[TBL] [Abstract][Full Text] [Related]
6. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
[TBL] [Abstract][Full Text] [Related]
7. Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general population.
Xu HH; Lin A; Chen YH; Dong SS; Shi WW; Yu JZ; Yan WH
BMJ Open; 2017 Jun; 7(6):e014135. PubMed ID: 28601819
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus genotypic characteristics of 60,685 subjects under age-expansion vaccination of the nine-valent human papillomavirus vaccine: A cross-sectional study.
Liu Y; Li Z; Yuan L; Liu F; Wu K; Xiao X; Zhu C
J Infect Public Health; 2023 Jul; 16(7):989-995. PubMed ID: 37167646
[TBL] [Abstract][Full Text] [Related]
9. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.
Wang R; Guo XL; Wisman GB; Schuuring E; Wang WF; Zeng ZY; Zhu H; Wu SW
BMC Infect Dis; 2015 Jul; 15():257. PubMed ID: 26142044
[TBL] [Abstract][Full Text] [Related]
10. Age-specific and genotype-specific carcinogenic human papillomavirus prevalence in a country with a high cervical cancer burden: results of a cross-sectional study in Estonia.
Pärna K; Nygård M; Tisler A; Toompere K; Naaber P; Ratnik K; Ķīvīte Urtāne A; Zodzika J; Stankūnas M; Baltzer N; Uusküla A
BMJ Open; 2023 Jun; 13(6):e069558. PubMed ID: 37263686
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Genotype Distribution of Human Papillomavirus Infection Among 40,613 Women: An Outpatient-Based Population Study in Kunming, Yunnan.
Zhang Y; Xu Y; Dian Z; Zhang G; Fan X; Zhao Y; Sun Y
Front Public Health; 2022; 10():922587. PubMed ID: 35923957
[TBL] [Abstract][Full Text] [Related]
12. Pattern of infection and genotypes of human papillomavirus in Zhengzhou City based on a four-year (2015-2018) epidemiological study.
Liu J; Wang C; Ma J; Wei S; Li Y; Chen X; Zhao Q; Huo Y
Women Health; 2023; 63(5):383-391. PubMed ID: 37280193
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of human papillomavirus infection and typing in Shanxi province].
Li J; Wang Y; Tian X; Wang P; Nan X; Yan T; Fu Y; Wang G; Liu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Mar; 48(3):192-6. PubMed ID: 24844832
[TBL] [Abstract][Full Text] [Related]
14. Genetic diversity of human papillomavirus (HPV) as specified by the detection method, gender, and year of sampling: a retrospective cross-sectional study.
Finan RR; Chemaitelly H; Racoubian E; Aimagambetova G; Almawi WY
Arch Gynecol Obstet; 2023 May; 307(5):1469-1479. PubMed ID: 36624228
[TBL] [Abstract][Full Text] [Related]
15. [Changes in genotype prevalence of human papillomavirus over 10-year follow-up of a cervical cancer screening cohort].
Dong L; Hu SY; Zhang Q; Feng RM; Zhang L; Zhao XL; Ma JF; Shi SD; Zhang X; Pan QJ; Zhang WH; Qiao YL; Zhao FH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):20-25. PubMed ID: 28100371
[No Abstract] [Full Text] [Related]
16. HPV prevalence and genotype distribution among women in eastern China during the Covid-19 pandemic.
Ma Y; Xia X; Zheng W; Dai Y; Zhuang X
Hum Vaccin Immunother; 2023 Dec; 19(1):2212571. PubMed ID: 37226673
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
18. [Study on subtype of human papillomavirus infection among aged 25 - 54 reproductive women in Beijing from 2006 to 2008].
Zhao R; Zhang WY; Zhang SW; Wu MH; Wang JD; Xie Z; Feng J; Pan J; Wang JH; Liu XZ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):184-7. PubMed ID: 21575451
[TBL] [Abstract][Full Text] [Related]
19. HPV genotype prevalence and distribution during 2009-2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination.
Wang J; Tang D; Wang K; Wang J; Zhang Z; Chen Y; Zhang X; Ma C
BMC Womens Health; 2019 Jul; 19(1):90. PubMed ID: 31286939
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study.
Liu XX; Fan XL; Yu YP; Ji L; Yan J; Sun AH
BMC Infect Dis; 2014 Dec; 14():708. PubMed ID: 25523884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
